Report this review of Pembrolizumab (Keytruda)
If you believe this review is inappropriate and breaks the terms and conditions of iWantGreatCare, please let us know by entering your email address and clicking the button below. Your email address is required to prevent abuse of the service through ensuring you are a real person. Your email address will not be used for marketing purposes, further information can be viewed in iWantGreatCare's privacy policy.
Pembrolizumab (Keytruda)
2019-05-17
Person
4
5
0
Written by a patient
Written by a patient 17th May 2019
I have just had my 20th session of immunotherapy.
14 months ago I was very weak and suffering from pneumonia, it was at this time that I was diagnosed with stage 4 lung cancer.
I feel that at the age of 76 I was very lucky to be offered immunotherapy and have not looked back since my first session, am now feeling pretty good except very short of breath and a bit of itching, small price to pay for 14 months of life.